Sionna Therapeutics Statistics
Total Valuation
SION has a market cap or net worth of $1.90 billion. The enterprise value is $1.62 billion.
Important Dates
The next estimated earnings date is Monday, August 10, 2026, before market open.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SION has 45.15 million shares outstanding. The number of shares has increased by 357.46% in one year.
| Current Share Class | 45.15M |
| Shares Outstanding | 45.15M |
| Shares Change (YoY) | +357.46% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 1.36% |
| Owned by Institutions (%) | 43.11% |
| Float | 16.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.60 |
| P/TBV Ratio | 6.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.60, with a Debt / Equity ratio of 0.03.
| Current Ratio | 22.60 |
| Quick Ratio | 22.11 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.74% and return on invested capital (ROIC) is -18.80%.
| Return on Equity (ROE) | -26.74% |
| Return on Assets (ROA) | -18.33% |
| Return on Invested Capital (ROIC) | -18.80% |
| Return on Capital Employed (ROCE) | -33.50% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.45M |
| Employee Count | 59 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +181.76% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +181.76% |
| 50-Day Moving Average | 39.87 |
| 200-Day Moving Average | 37.64 |
| Relative Strength Index (RSI) | 60.41 |
| Average Volume (20 Days) | 456,669 |
Short Selling Information
The latest short interest is 4.64 million, so 10.27% of the outstanding shares have been sold short.
| Short Interest | 4.64M |
| Short Previous Month | 4.74M |
| Short % of Shares Out | 10.27% |
| Short % of Float | 27.62% |
| Short Ratio (days to cover) | 12.48 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -98.92M |
| Pretax Income | -85.57M |
| Net Income | -85.57M |
| EBITDA | -98.28M |
| EBIT | -98.92M |
| Earnings Per Share (EPS) | -$1.92 |
Full Income StatementBalance Sheet
The company has $216.15 million in cash and $8.38 million in debt, giving a net cash position of $281.55 million or $6.24 per share.
| Cash & Cash Equivalents | 216.15M |
| Total Debt | 8.38M |
| Net Cash | 281.55M |
| Net Cash Per Share | $6.24 |
| Equity (Book Value) | 288.21M |
| Book Value Per Share | 6.39 |
| Working Capital | 211.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$71.85 million and capital expenditures -$291,000, giving a free cash flow of -$72.14 million.
| Operating Cash Flow | -71.85M |
| Capital Expenditures | -291,000 |
| Depreciation & Amortization | 642,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -72.14M |
| FCF Per Share | -$1.60 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |